Hims vs Wellorithm: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

49 providers verified independently·Independent research·How we rank →

Hims beats Wellorithm overall, scoring 7.9/10 vs 7.4/10. Wellorithm is more affordable at $147/mo vs $199/mo. Choose Hims for men who want a well-known publicly-traded brand and fda-appr. Choose Wellorithm for cash-pay patients who want compounded semaglutide or tirzepa.

A side-by-side comparison of Hims and Wellorithm covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

Hims

#12 of 49

7.9/10

The household name in men's telehealth, publicly traded as Hims & Hers Health (NYSE: HIMS). In 2026 Hims added FDA-approved brand-name Wegovy (injection and pill) and Ozempic through a direct Novo Nordisk partnership — alongside their existing compounded semaglutide program. Brand recognition and product breadth are real strengths. The trade-off: Hims' verified Trustpilot rating is 3.0 stars across 8,286 reviews (May 2026) — significantly below smaller competitors like Henry Meds (4.5) or Eden Health (4.5). The 1-star pool is 28% — the highest 1-star rate in our table — clustered around subscription/billing complaints.

Visit Hims

Wellorithm

#30 of 49

7.4/10

Telehealth platform for compounded semaglutide and tirzepatide that uniquely offers BOTH injectable and oral dissolving tablet formats, paired with a 10% weight-loss guarantee that refunds up to four months of program fees if the patient does not lose at least 10% of baseline weight after 16 weeks of medication adherence (terms apply). 28-day recurring billing, non-refundable per-cycle, with a documented address listed in Berlin, Germany.

Visit Wellorithm

Feature	Hims	Wellorithm
Our Score	7.9/10	7.4/10
Starting Price	$199/mo	$147/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Men who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership — but should know going in that Hims' customer-experience signal is weaker than smaller competitors	Cash-pay patients who want compounded semaglutide or tirzepatide with the option of oral dissolving tablets (rare), a 10% weight-loss money-back guarantee, and 24/7 support — and who are comfortable enrolling with a platform that does not publicly disclose its founders, headquarters, or named prescribers
Ranking	#12	#30

Pros & Cons Compared

Hims

Pros

+Publicly traded company (NYSE: HIMS) — SEC-filed financials, regulatory accountability that private competitors don't have.
+2026 Novo Nordisk partnership — FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims. Real brand-name access from a single platform.
+$199/mo all-inclusive for compounded semaglutide, including consultations and shipping.
+Polished app and web experience — among the best user interfaces in men's telehealth.
+8,286 verified Trustpilot reviews is the second-largest review volume in our table (after Henry's 12,461) — significant real-world adoption.

Cons

−Trustpilot rating is 3.0 stars / 8,286 reviews (May 2026) — significantly below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.
−28% of Trustpilot reviews are 1-star — the highest 1-star rate in our table. Top complaint themes: subscription handling, unexpected charges, customer service responsiveness.
−Hims reviews span ALL their products (ED, hair loss, mental health, weight loss) — not just GLP-1. But the rating still applies because most users don't separate experiences by product.
−'Hims Oral Kit' is NOT a GLP-1 — it's a non-GLP-1 metabolic combination (metformin + bupropion + topiramate + B12 + naltrexone). Easy to confuse with their compounded semaglutide. Read the product page carefully before signing up.
−Brand Wegovy at $599/mo is not competitive with LillyDirect/NovoCare cash prices or with Hers ($149/mo for the same product via the same Novo partnership).
−Generic high-volume support — large patient base means less personalized attention than smaller competitors.

Wellorithm

Pros

+Compounded GLP-1 available in BOTH injectable AND oral dissolving tablet formats — semaglutide and tirzepatide each in two formats — broader format menu than most compounded-only platforms
+10% weight-loss money-back guarantee: patients who don't lose at least 10% of baseline weight after 16 weeks of medication adherence may be eligible for refund of up to four months of program fees (verified weight documentation required)
+Competitive entry pricing — $147/mo compounded semaglutide and $249/mo compounded tirzepatide put Wellorithm near the cheaper end of the compounded market
+2-minute qualification quiz, virtual consultation, 24/7 support availability claimed
+23,000+ reviews and 4.9-star rating reported (volume is unusually high for this market segment — verify on independent third-party sources before relying on it)
+Spring promotion advertised at $147 with free shipping included

Cons

−Founding year, corporate ownership, and named prescribers are NOT publicly disclosed — the only address listed is a German one (Berlin, DE 81566), unusual for a platform serving US patients
−49 states only — service is unavailable in Louisiana and outside the United States
−28-day recurring billing cycle with payments non-refundable once processed — strict cancellation policy and no proration for partial months
−Compounded-only — no FDA-approved Wegovy, Zepbound, Ozempic, Mounjaro, or Foundayo; FDA does not review compounded medications for safety, effectiveness, or manufacturing quality
−Weight-loss guarantee terms are restrictive: requires verified weight documentation (doctor attestation or video evidence), prior medication history disclosure, consistent dosing adherence, and refund processed within 30 days of approval — only fees actually paid are refundable, baseline payments remain non-refundable
−Two different affiliate landing pages (campaign-7 and qoroxapi/lead.php direct route) with different funnel structures suggest the platform tests multiple lead-capture flows, which can create inconsistent post-click experiences

Our Verdict

Hims edges out Wellorithm with a score of 7.9/10 vs 7.4/10. If budget is your priority, Wellorithm starts at $147/mo compared to Hims's $199/mo. Hims offers both brand-name and compounded medications, giving you more flexibility. Choose Hims if you want: men who want a well-known publicly-traded brand and fda-approved wegovy through the 2026 novo nordisk partnership — but should know going in that hims' customer-experience signal is weaker than smaller competitors. Choose Wellorithm if you want: cash-pay patients who want compounded semaglutide or tirzepatide with the option of oral dissolving tablets (rare), a 10% weight-loss money-back guarantee, and 24/7 support — and who are comfortable enrolling with a platform that does not publicly disclose its founders, headquarters, or named prescribers.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Hims nor Wellorithm feels like the right fit, our overall #1 pick across all 49 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review